International Screening Standards - IBBIS
webCredibility Rating
High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: International Biosecurity and Biosafety Initiative
Relevant to AI safety discussions around dual-use risks, as AI-assisted DNA design and synthesis could lower barriers to bioweapons development; IBBIS screening standards represent one governance layer aimed at mitigating this risk.
Metadata
Summary
IBBIS (International Biosecurity and Biosafety Initiative for Science) develops and promotes international standards for screening DNA synthesis orders to prevent misuse for biological weapons development. The initiative works to establish harmonized screening protocols that DNA synthesis providers worldwide can adopt to identify potentially dangerous sequences before fulfilling orders. This represents a key governance mechanism for biosecurity in the emerging synthetic biology sector.
Key Points
- •Promotes harmonized international standards for DNA synthesis screening to reduce biological weapons proliferation risk
- •Addresses the gap in biosecurity oversight as DNA synthesis becomes cheaper and more accessible globally
- •Works with governments, industry, and scientific community to develop technically sound and implementable screening protocols
- •Screening standards aim to identify sequences of concern (e.g., select agents, enhanced pathogens) before synthesis is completed
- •Represents a coordination effort to prevent a patchwork of inconsistent national regulations creating exploitable gaps
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| IBBIS (International Biosecurity and Biosafety Initiative for Science) | Organization | 60.0 |
Cached Content Preview
- [About](https://ibbis.bio/about/)
- [People](https://ibbis.bio/about/people/)
- [Careers](https://ibbis.bio/about/careers/)
- [News](https://ibbis.bio/news/)
- [Our Work](https://ibbis.bio/our-work/)
- [Commec Sequence Screening](https://ibbis.bio/our-work/common-mechanism/)
- [Customer Screening](https://ibbis.bio/our-work/customer-screening/)
- [Global Synthesis Map](https://ibbis.bio/our-work/global-dna-synthesis-map/)
- [International Standards](https://ibbis.bio/our-work/international-screening-standards/)
- [Sequence Biosecurity Standards](https://ibbis.bio/our-work/sequence-biosecurity-standards/)
- [Vulnerability Disclosure](https://ibbis.bio/our-work/vulnerability-disclosure/)
- [Contact](https://ibbis.bio/contact/)
[](https://ibbis.bio/)
- [About](https://ibbis.bio/about/)
- [People](https://ibbis.bio/about/people/)
- [Careers](https://ibbis.bio/about/careers/)
- [News](https://ibbis.bio/news/)
- [Our Work](https://ibbis.bio/our-work/)
- [Commec Sequence Screening](https://ibbis.bio/our-work/common-mechanism/)
- [Customer Screening](https://ibbis.bio/our-work/customer-screening/)
- [Global Synthesis Map](https://ibbis.bio/our-work/global-dna-synthesis-map/)
- [International Standards](https://ibbis.bio/our-work/international-screening-standards/)
- [Sequence Biosecurity Standards](https://ibbis.bio/our-work/sequence-biosecurity-standards/)
- [Vulnerability Disclosure](https://ibbis.bio/our-work/vulnerability-disclosure/)
- [Contact](https://ibbis.bio/contact/)
International Screening Standards
# **Supporting common international standards for DNA synthesis screening**
IBBIS seeks to support standards for DNA synthesis screening that are international, inclusive and rigorous. There has been increasing interest in harmonizing and standardizing screening approaches around the world, especially in light of national and international guidance released in 2024 and concerns that advances in artificial intelligence will increase the risk that synthetic nucleic acids are misused. By promoting and enhancing emerging standards, we aim to prevent fragmentation of synthesis screening methodology while improving baseline practices.
**The [DNA Synthesis Screening Consortium (DSSC)](https://ibbis.bio/dna-screening-standards-consortium/), our flagship initiative under the International Standards programme, drives much of this work.**
Launch
Stakeholder engagement starting January 2025
Now
Developing recommendations to strengthen existing standards
Future
Harmonized guidance for policymakers and standards bodies
## Challenge: a fragmented landscape of voluntary guidance
Voluntary standards for sequence and customer screening have already been adopted by providers aiming to comply with their national export controls and biosecurity guidance. However, this adoption remains uneven, particularly among smaller providers. In the past few
... (truncated, 14 KB total)8ecf5545b27f07a5 | Stable ID: N2RlZjlmN2